Clinical trials sponsored by Beijing Tiantan Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Beijing Tiantan Hospital

• China HeadAche DIsorders RegiStry
  NCT05334927 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · 61 locations
• China National Registry of Neuro-Inflammatory Diseases
  NCT05154370 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Cervicogenic Headache
  NCT07347730 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Migraine
  NCT07347067 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA)
  NCT07347041 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: All (male and female) · 2 locations
• Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Knee Osteoarthritis(OA)
  NCT07347028 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: All (male and female) · 1 location
• Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Shoulder Osteoarthritis(OA)
  NCT07347054 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: All (male and female) · 1 location
• Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
  NCT04106830 · Phase: Not specified · Ages: 16 Years to 75 Years · Sex: All (male and female) · 1 location
• Deep Cervical Lymphatic Venous Anastomosis in the Treatment of Alzheimer's Disease (CLEAN-AD)
  NCT07073066 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 9 locations
• Effects of Propofol on Brain Function in Patients With Parkinson's Disease
  NCT05895019 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Environmental Pollutants and Neurological Disorders
  NCT07140601 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Esketamine in Microelectrode Recording-guided Subthalamic Deep-Brain Stimulation for Parkinson's Disease
  NCT06543563 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• High-density Flexible μECoG for Epilepsy Surgery - A Single-Arm ECT
  NCT07656857 · Phase: Not applicable (e.g. observational or device study) · Ages: 3 Years to 60 Years · Sex: All (male and female) · 1 location
• Impact of Frequency-specific Subthalamic Nucleus Subregion Stimulation on Inhibitory Control in Parkinson's Disease
  NCT07022522 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• Levetiracetam for Seizure Prevention After Brain Tumor Surgery
  NCT07239115 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• MRgLITT for mTLE: A PROBE Trial
  NCT06720922 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Mechanism and Application of DBS in the Treatment of PD
  NCT06400017 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 70 Years · Sex: All (male and female) · 1 location
• Mechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage
  NCT06906432 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Registry of Multicenter Brain-Heart Comorbidity in China
  NCT05961748 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)
  NCT05707442 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers
  NCT07392411 · Phase: Not specified · Ages: 15 Years to 75 Years · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Pregabalin Combined With Desvenlafaxine in Patients With Fibromyalgia
  NCT07171320 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Pregabalin Combined With Dexmedetomidine in Patients With Fibromyalgia
  NCT07230197 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Pregabalin Combined With Toludesvenlafaxine in Patients With Fibromyalgia
  NCT07208357 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia
  NCT07186751 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With Fibromyalgia
  NCT07196657 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia
  NCT07157852 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia
  NCT07230171 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult
  NCT06322407 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Beijing Tiantan Hospital recruiting for?

Beijing Tiantan Hospital is the lead sponsor of 29 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.